Suspected Chinese whistleblower returns to work at GSK
UK pharmaceutical company GlaxoSmithKline (GSK) has rehired its former China head of government affairs, who was suspected of making whistleblower complaints that led to China fining the company £297 million for bribery.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.